Lilly to Participate in Guggenheim Biopharma Strategy Series

INDIANAPOLIS , June 14, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation – on Friday, June 18, 2021 . Daniel Skovronsky , M.D., Ph.D., Lilly 's Chief